A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| SARS-CoV-2 NucleoProtein 305-319 | SARS-CoV-2 NucleoProtein 305-319 is the 305-319 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Ala-Gln-Phe-Ala-Pro-Ser-Ala-Ser-Ala-Phe-Phe-Gly-Met-Ser-Arg. Molecular formula: C71H103N19O20S. Mole weight: 1574.82. |  |
| SARS-CoV-2 NucleoProtein 305-322 | SARS-CoV-2 NucleoProtein 305-322 is the 305-322 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Ala-Gln-Phe-Ala-Pro-Ser-Ala-Ser-Ala-Phe-Phe-Gly-Met-Ser-Arg-Ile-Gly-Met. Molecular formula: C84H126N22O23S2. Mole weight: 1876.25. | |
| SARS-CoV-2 NucleoProtein 313-330 | SARS-CoV-2 NucleoProtein 313-330 is the 313-330 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Ala-Phe-Phe-Gly-Met-Ser-Arg-Ile-Gly-Met-Glu-Val-Thr-Pro-Ser-Gly-Thr-Trp. Molecular formula: C89H132N22O25S2. Mole weight: 1974.37. | |
| SARS-CoV-2 NucleoProtein 316-324 | SARS-CoV-2 NucleoProtein 316-324 is the 316-324 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Gly-Met-Ser-Arg-Ile-Gly-Met-Glu-Val. Molecular formula: C39H70N12O13S2. Mole weight: 979.23. | |
| SARS-CoV-2 NucleoProtein 320-334 | SARS-CoV-2 NucleoProtein 320-334 is the 320-334 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Ile-Gly-Met-Glu-Val-Thr-Pro-Ser-Gly-Thr-Trp-Leu-Thr-Tyr-Thr. Molecular formula: C75H114N16O24S. Mole weight: 1655.97. | |
| SARS-CoV-2 NucleoProtein 322-331 | SARS-CoV-2 NucleoProtein 322-331 is the 322-331 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Met-Glu-Val-Thr-Pro-Ser-Gly-Thr-Trp-Leu. Molecular formula: C50H77N11O16S. Mole weight: 1120.34. | |
| SARS-CoV-2 NucleoProtein 325-339 | SARS-CoV-2 NucleoProtein 325-339 is the 325-339 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Thr-Pro-Ser-Gly-Thr-Trp-Leu-Thr-Tyr-Thr-Gly-Ala-Ile-Lys-Leu. Molecular formula: C75H117N17O22. Mole weight: 1608.94. | |
| SARS-CoV-2 NucleoProtein 329-346 | SARS-CoV-2 NucleoProtein 329-346 is the 329-346 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Thr-Trp-Leu-Thr-Tyr-Thr-Gly-Ala-Ile-Lys-Leu-Asp-Asp-Lys-Asp-Pro-Asn-Phe. Molecular formula: C97H144N22O30. Mole weight: 2098.43. | |
| SARS-CoV-2 NucleoProtein 329-353 | SARS-CoV-2 NucleoProtein 329-353 is the 329-353 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Thr-Trp-Leu-Thr-Tyr-Thr-Gly-Ala-Ile-Lys-Leu-Asp-Asp-Lys-Asp-Pro-Asn-Phe-Lys-Asp-Gln-Val-Ile-Leu-Leu. Molecular formula: C135H211N31O40. Mole weight: 2908.49. | |
| SARS-CoV-2 NucleoProtein 351-358 | SARS-CoV-2 NucleoProtein 351-358 is the 351-358 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Ile-Leu-Leu-Asn-Lys-His-Ile-Asp. Molecular formula: C44H76N12O12. Mole weight: 965.22. | |
| SARS-CoV-2 NucleoProtein 351-359 | SARS-CoV-2 NucleoProtein 351-359 is the 351-359 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Ile-Leu-Leu-Asn-Lys-His-Ile-Asp-Ala. Molecular formula: C47H81N13O13. Mole weight: 1036.3. | |
| SARS-CoV-2 NucleoProtein 352-369 | SARS-CoV-2 NucleoProtein 352-369 is the 352-369 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Leu-Leu-Asn-Lys-His-Ile-Asp-Ala-Tyr-Lys-Thr-Phe-Pro-Pro-Thr-Glu-Pro-Lys. Molecular formula: C99H154N24O27. Mole weight: 2112.55. | |
| SARS-CoV-2 NucleoProtein 360-375 | SARS-CoV-2 NucleoProtein 360-375 is the 360-375 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Tyr-Lys-Thr-Phe-Pro-Pro-Thr-Glu-Pro-Lys-Lys-Asp-Lys-Lys-Lys-Lys. Molecular formula: C92H151N23O24. Mole weight: 1963.42. | |
| SARS-CoV-2 NucleoProtein 40-54 | SARS-CoV-2 NucleoProtein 40-54 is the 40-54 amino acid residue of SARS-CoV-2 NucleoProtein. SARS-CoV-2 NucleoProtein is an abundant RNA-binding protein critical for viral genome packaging. Alternative Names: Arg-Arg-Pro-Gln-Gly-Leu-Pro-Asn-Asn-Thr-Ala-Ser-Trp-Phe-Thr. Molecular formula: C77H117N25O22. Mole weight: 1745. | |
| SARS-CoV-2 Spike GlycoProtein 1011-1028 | SARS-CoV-2 Spike GlycoProtein 1011-1028 is the 1011-1028 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Gln-Leu-Ile-Arg-Ala-Ala-Glu-Ile-Arg-Ala-Ser-Ala-Asn-Leu-Ala-Ala-Thr-Lys. Molecular formula: C81H145N27O25. Mole weight: 1897.29. | |
| SARS-CoV-2 Spike GlycoProtein 1060-1068 | SARS-CoV-2 Spike GlycoProtein 1060-1068 is the 1060-1068 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Val-Val-Phe-Leu-His-Val-Thr-Tyr-Val. Molecular formula: C54H81N11O12. Mole weight: 1076.36. | |
| SARS-CoV-2 Spike GlycoProtein 1185-1193 | SARS-CoV-2 Spike GlycoProtein 1185-1193 is the 1185-1193 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Arg-Leu-Asn-Glu-Val-Ala-Lys-Asn-Leu. Molecular formula: C45H81N15O14. Mole weight: 1056.28. | |
| SARS-CoV-2 Spike GlycoProtein 1192-1200 | SARS-CoV-2 Spike GlycoProtein 1192-1200 is the 1192-1200 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Asn-Leu-Asn-Glu-Ser-Leu-Ile-Asp-Leu. Molecular formula: C44H75N11O17. Mole weight: 1030.2. | |
| SARS-CoV-2 Spike GlycoProtein 1220-1228 | SARS-CoV-2 Spike GlycoProtein 1220-1228 is the 1220-1228 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Phe-Ile-Ala-Gly-Leu-Ile-Ala-Ile-Val. Molecular formula: C46H77N9O10. Mole weight: 916.23. | |
| SARS-CoV-2 Spike GlycoProtein 424-433 | SARS-CoV-2 Spike GlycoProtein 424-433 is the 424-433 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Lys-Leu-Pro-Asp-Asp-Phe-Thr-Gly-Cys-Val. Molecular formula: C48H75N11O16S. Mole weight: 1094.29. | |
| SARS-CoV-2 Spike GlycoProtein 647-664 | SARS-CoV-2 Spike GlycoProtein 647-664 is the 647-664 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Ala-Gly-Cys-Leu-Ile-Gly-Ala-Glu-His-Val-Asn-Asn-Ser-Tyr-Glu-Cys-Asp-Ile. Molecular formula: C79H122N22O29S2. Mole weight: 1908.18. | |
| SARS-CoV-2 Spike GlycoProtein 691-699 | SARS-CoV-2 Spike GlycoProtein 691-699 is the 691-699 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Ser-Ile-Ile-Ala-Tyr-Thr-Met-Ser-Leu. Molecular formula: C45H75N9O14S. Mole weight: 998.25. | |
| SARS-CoV-2 Spike GlycoProtein 747-763 | SARS-CoV-2 Spike GlycoProtein 747-763 is the 747-763 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Thr-Glu-Cys-Ser-Asn-Leu-Leu-Leu-Gln-Tyr-Gly-Ser-Phe-Cys-Thr-Gln-Leu. Molecular formula: C83H130N20O28S2. Mole weight: 1920.28. | |
| SARS-CoV-2 Spike GlycoProtein 891-906 | SARS-CoV-2 Spike GlycoProtein 891-906 is the 891-906 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Gly-Ala-Ala-Leu-Gln-Ile-Pro-Phe-Ala-Met-Gln-Met-Ala-Tyr-Arg-Phe. Molecular formula: C84H127N21O20S2. Mole weight: 1815.26. | |
| SARS-CoV-2 Spike GlycoProtein 902-917 | SARS-CoV-2 Spike GlycoProtein 902-917 is the 902-917 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Met-Ala-Tyr-Arg-Phe-Asn-Gly-Ile-Gly-Val-Thr-Gln-Asn-Val-Leu-Tyr. Molecular formula: C84H128N22O23S. Mole weight: 1846.23. | |
| SARS-CoV-2 Spike GlycoProtein 957-973 | SARS-CoV-2 Spike GlycoProtein 957-973 is the 957-973 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Gln-Ala-Leu-Asn-Thr-Leu-Val-Lys-Gln-Leu-Ser-Ser-Asn-Phe-Gly-Ala-Ile. Molecular formula: C80H134N22O25. Mole weight: 1804.18. | |
| SARS-CoV-2 Spike GlycoProtein 958-966 | SARS-CoV-2 Spike GlycoProtein 958-966 is the 958-966 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Ala-Leu-Asn-Thr-Leu-Val-Lys-Gln-Leu. Molecular formula: C45H82N12O13. Mole weight: 999.28. | |
| SARS-CoV-2 Spike GlycoProtein 976-984 | SARS-CoV-2 Spike GlycoProtein 976-984 is the 976-984 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Val-Leu-Asn-Asp-Ile-Leu-Ser-Arg-Leu. Molecular formula: C46H83N13O14. Mole weight: 1042.3. | |
| SARS-CoV-2 Spike GlycoProtein 996-1004 | SARS-CoV-2 Spike GlycoProtein 996-1004 is the 996-1004 amino acid residue of SARS-CoV-2 Spike GlycoProtein. SARS-CoV-2 Spike GlycoProtein is composed of S1 and S2 subunits. The S1 subunit contains a receptor-binding domain that recognizes and binds to the host receptor angiotensin-converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. Alternative Names: Leu-Ile-Thr-Gly-Arg-Leu-Gln-Ser-Leu. Molecular formula: C44H81N13O13. Mole weight: 1000.27. | |
| SARS-CoV-2 Spike RBD (receptor binding domain) 319-335 | SARS-CoV-2 Spike RBD (receptor binding domain) 319-335 is the 319-335 amino acid residue of SARS-CoV-2 Spike RBD (receptor binding domain), which can recognize and bind to angiotensin-converting enzyme 2 (ACE2) receptor. SARS-CoV-2 Spike RBD has the potential to be developed as therapeutics and prophylactics against SARS-CoV-2. Alternative Names: H-Arg-Val-Gln-Pro-Thr-Glu-Ser-Ile-Val-Arg-Phe-Pro-Asn-Ile-Thr-Asn-Leu-OH; Arg-Val-Gln-Pro-Thr-Glu-Ser-Ile-Val-Arg-Phe-Pro-Asn-Ile-Thr-Asn-Leu. Molecular formula: C88H146N26O26. Mole weight: 1984.38. | |
| SARS-CoV-2 Spike RBD (receptor binding domain) 336-347 | SARS-CoV-2 Spike RBD (receptor binding domain) 336-347 is the 336-347 amino acid residue of SARS-CoV-2 Spike RBD (receptor binding domain), which can recognize and bind to angiotensin-converting enzyme 2 (ACE2) receptor. SARS-CoV-2 Spike RBD has the potential to be developed as therapeutics and prophylactics against SARS-CoV-2. Alternative Names: H-Cys-Pro-Phe-Gly-Glu-Val-Phe-Asn-Ala-Thr-Arg-Phe-OH; Cys-Pro-Phe-Gly-Glu-Val-Phe-Asn-Ala-Thr-Arg-Phe. Molecular formula: C64H90N16O17S. Mole weight: 1387.62. | |
| SARS-CoV-2 Spike RBD (receptor binding domain) 348-357 | SARS-CoV-2 Spike RBD (receptor binding domain) 348-357 is the 348-357 amino acid residue of SARS-CoV-2 Spike RBD (receptor binding domain), which can recognize and bind to angiotensin-converting enzyme 2 (ACE2) receptor. SARS-CoV-2 Spike RBD has the potential to be developed as therapeutics and prophylactics against SARS-CoV-2. Alternative Names: H-Ala-Ser-Val-Tyr-Ala-Trp-Asn-Arg-Lys-Arg-OH; Ala-Ser-Val-Tyr-Ala-Trp-Asn-Arg-Lys-Arg. Molecular formula: C56H87N19O14. Mole weight: 1250.46. | |
| SARS-CoV-2 Spike RBD (receptor binding domain) 352-365 | SARS-CoV-2 Spike RBD (receptor binding domain) 352-365 is the 352-365 amino acid residue of SARS-CoV-2 Spike RBD (receptor binding domain), which can recognize and bind to angiotensin-converting enzyme 2 (ACE2) receptor. SARS-CoV-2 Spike RBD has the potential to be developed as therapeutics and prophylactics against SARS-CoV-2. Alternative Names: H-Ala-Trp-Asn-Arg-Lys-Arg-Ile-Ser-Asn-Cys-Val-Ala-Asp-Tyr-OH; Ala-Trp-Asn-Arg-Lys-Arg-Ile-Ser-Asn-Cys-Val-Ala-Asp-Tyr. Molecular formula: C73H114N24O21S. Mole weight: 1695.97. | |
| SARS-CoV-2 Spike RBD (receptor binding domain) 371-394 | SARS-CoV-2 Spike RBD (receptor binding domain) 371-394 is the 371-394 amino acid residue of SARS-CoV-2 Spike RBD (receptor binding domain), which can recognize and bind to angiotensin-converting enzyme 2 (ACE2) receptor. SARS-CoV-2 Spike RBD has the potential to be developed as therapeutics and prophylactics against SARS-CoV-2. Alternative Names: H-Ser-Ala-Ser-Phe-Ser-Thr-Phe-Lys-Cys-Tyr-Gly-Val-Ser-Pro-Thr-Lys-Leu-Asn-Asp-Leu-Cys-Phe-Thr-Asn-OH; Ser-Ala-Ser-Phe-Ser-Thr-Phe-Lys-Cys-Tyr-Gly-Val-Ser-Pro-Thr-Lys-Leu-Asn-Asp-Leu-Cys-Phe-Thr-Asn. Molecular formula: C117H176N28O37S2. Mole weight: 2631.07. | |
| SARS-CoV-2 Spike RBD (receptor binding domain) 395-430 | SARS-CoV-2 Spike RBD (receptor binding domain) 395-430 is the 395-430 amino acid residue of SARS-CoV-2 Spike RBD (receptor binding domain), which can recognize and bind to angiotensin-converting enzyme 2 (ACE2) receptor. SARS-CoV-2 Spike RBD has the potential to be developed as therapeutics and prophylactics against SARS-CoV-2. Alternative Names: H-Val-Tyr-Ala-Asp-Ser-Phe-Val-Ile-Arg-Gly-Asp-Glu-Val-Arg-Gln-Ile-Ala-Pro-Gly-Gln-Thr-Gly-Lys-Ile-Ala-Asp-Tyr-Asn-Tyr-Lys-Leu-Pro-Asp-Asp-Phe-Thr-OH; Val-Tyr-Ala-Asp-Ser-Phe-Val-Ile-Arg-Gly-Asp-Glu-Val-Arg-Gln-Ile-Ala-Pro-Gly-Gln-Thr-Gly-Lys-Ile-Ala-Asp-Tyr-Asn-Tyr-Lys-Leu-Pro-Asp-Asp-Phe-Thr. Molecular formula: C183H277N47O58. Mole weight: 4063.67. | |
| SARS-CoV-2 Spike RBD (receptor binding domain) 513-520 | SARS-CoV-2 Spike RBD (receptor binding domain) 513-520 is the 513-520 amino acid residue of SARS-CoV-2 Spike RBD (receptor binding domain), which can recognize and bind to angiotensin-converting enzyme 2 (ACE2) receptor. SARS-CoV-2 Spike RBD has the potential to be developed as therapeutics and prophylactics against SARS-CoV-2. Alternative Names: H-Leu-Ser-Phe-Glu-Leu-Leu-His-Ala-OH; Leu-Ser-Phe-Glu-Leu-Leu-His-Ala. Molecular formula: C44H68N10O12. Mole weight: 929.13. | |
| SARS-CoV-2 Spike RBD (receptor binding domain) 523-541 | SARS-CoV-2 Spike RBD (receptor binding domain) 523-541 is the 523-541 amino acid residue of SARS-CoV-2 Spike RBD (receptor binding domain), which can recognize and bind to angiotensin-converting enzyme 2 (ACE2) receptor. SARS-CoV-2 Spike RBD has the potential to be developed as therapeutics and prophylactics against SARS-CoV-2. Alternative Names: H-Thr-Val-Cys-Gly-Pro-Lys-Lys-Ser-Thr-Asn-Leu-Val-Lys-Asn-Lys-Cys-Val-Asn-Phe-OH; Thr-Val-Cys-Gly-Pro-Lys-Lys-Ser-Thr-Asn-Leu-Val-Lys-Asn-Lys-Cys-Val-Asn-Phe. Molecular formula: C90H154N26O26S2. Mole weight: 2080.59. | |
| SARS-CoV-2 Spike RBM (receptor binding motif) 438-458 | SARS-CoV-2 Spike RBM (receptor binding motif) 438-458 is the 438-458 amino acid residue of SARS-CoV-2 Spike RBM (receptor binding motif), the main functional motif in RBD. SARS-CoV-2 Spike RBM is composed of two regions (region 1 and region 2) that form the interface of the S protein with hACE2. Alternative Names: H-Ser-Asn-Asn-Leu-Asp-Ser-Lys-Val-Gly-Gly-Asn-Tyr-Asn-Tyr-Leu-Tyr-Arg-Leu-Phe-Arg-Lys-OH; Ser-Asn-Asn-Leu-Asp-Ser-Lys-Val-Gly-Gly-Asn-Tyr-Asn-Tyr-Leu-Tyr-Arg-Leu-Phe-Arg-Lys. Molecular formula: C113H173N33O33. Mole weight: 2521.93. | |
| SARS-CoV-2 Spike RBM (receptor binding motif) 450-473 | SARS-CoV-2 Spike RBM (receptor binding motif) 450-473 is the 450-473 amino acid residue of SARS-CoV-2 Spike RBM (receptor binding motif), the main functional motif in RBD. SARS-CoV-2 Spike RBM is composed of two regions (region 1 and region 2) that form the interface of the S protein with hACE2. Alternative Names: H-Asn-Tyr-Leu-Tyr-Arg-Leu-Phe-Arg-Lys-Ser-Asn-Leu-Lys-Pro-Phe-Glu-Arg-Asp-Ile-Ser-Thr-Glu-Ile-Tyr-OH; Asn-Tyr-Leu-Tyr-Arg-Leu-Phe-Arg-Lys-Ser-Asn-Leu-Lys-Pro-Phe-Glu-Arg-Asp-Ile-Ser-Thr-Glu-Ile-Tyr. Molecular formula: C142H217N37O39. Mole weight: 3066.63. | |
| SARS-CoV-2 Spike RBM (receptor binding motif) 480-496 | SARS-CoV-2 Spike RBM (receptor binding motif) 480-496 is the 480-496 amino acid residue of SARS-CoV-2 Spike RBM (receptor binding motif), the main functional motif in RBD. SARS-CoV-2 Spike RBM is composed of two regions (region 1 and region 2) that form the interface of the S protein with hACE2. Alternative Names: H-Cys-Asn-Gly-Val-Glu-Gly-Phe-Asn-Cys-Tyr-Phe-Pro-Leu-Gln-Ser-Tyr-Gly-OH; Cys-Asn-Gly-Val-Glu-Gly-Phe-Asn-Cys-Tyr-Phe-Pro-Leu-Gln-Ser-Tyr-Gly. Molecular formula: C85H116N20O26S2. Mole weight: 1898.18. | |
| SARS-CoV-2 Spike RBM (receptor binding motif) 500-509 | SARS-CoV-2 Spike RBM (receptor binding motif) 500-509 is the 500-509 amino acid residue of SARS-CoV-2 Spike RBM (receptor binding motif), the main functional motif in RBD. SARS-CoV-2 Spike RBM is composed of two regions (region 1 and region 2) that form the interface of the S protein with hACE2. Alternative Names: H-Thr-Asn-Gly-Val-Gly-Tyr-Gln-Pro-Tyr-Arg-OH; Thr-Asn-Gly-Val-Gly-Tyr-Gln-Pro-Tyr-Arg. Molecular formula: C51H75N15O16. Mole weight: 1154.3. | |
| Sartorypyrone A | Sartorypyrone A is a meroditerpene metabolite produced by Neosartorya fungal species, displaying antibacterial and antibiofilm activities. It shows inhibitory effects against various Gram-positive bacteria. It also suppresses the growth of MCF-7 breast, NCI-H460 lung and A375-C5 melanoma cancer cell lines. Alternative Names: 20-O-Acetyl Sartorypyrone D; rel-(+)-3-[(2E,6E)-9-[(1R,3S)-3-(acetyloxy)-2,2-dimethyl-6-methylenecyclohexyl]-3,7-dimethyl-2,6-nonadien-1-yl]-4-hydroxy-6-methyl-2H-pyran-2-one. Grades: ≥95%. CAS No. 1452396-10-9. Molecular formula: C28H40O5. Mole weight: 456.61. | |
| Sarubicin B | It is produced by the strain of Str. violaceoruber sp. JA 2861. It has anti-gram-positive bacteria effect, but no anti-gram-negative bacteria, fungi and yeast effects. Alternative Names: 2-Naphthalenecarboxamide, 5-acetyl-3-amino-1,4-dihydro-1,4-dioxo-. CAS No. 84745-01-7. Molecular formula: C13H10N2O4. Mole weight: 258.23. | |
| S-(+)-Arundic acid | S-(+)-Arundic acid. Group: Biochemicals. Alternative Names: (2S)-2-Propyloctanoic acid; (S)-(+)-2-Propyloctanoic acid. Grades: Highly Purified. CAS No. 807363-10-6. Pack Sizes: 1mg, 2mg, 5mg, 10mg, 25mg. Molecular Formula: C11H22O2. US Biological Life Sciences. |  Worldwide |
| Saruparib | Saruparib (AZD5305) is a potent, orally active and selective PARP inhibitor and trapper with IC50 values of 3 nM and 1400 nM for PARP1 and PARP2, respectively. Saruparib has anti-proliferative activity and inhibits growth in cells with deficiencies in DNA repair[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AZD5305. CAS No. 2589531-76-8. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-132167. |  |
| Sasanlimab | Sasanlimab is a humanized IgG4 isotype anti-PD-1 antibody. Sasanlimab blocks PD-1 interaction with PD-L1/PD-L2, reverses PD-1-mediated inhibitory T-cell signaling, augments T-cell proliferation and cytokine production. Sasanlimab inhibits colon adenocarcinoma tumor growth, and accelerates graft-versus-host disease incidence via enhanced T-cell activity. Sasanlimab can be used for the research of cancer, such as bladder cancer and colon adenocarcinoma[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PF-06801591. CAS No. 2206792-50-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99884. | |
| SATA | SATA. CAS No. 76931-93-6. Pack Sizes: Milligram Quantities: 100 mg. Order Number: M101. |  www.prochemonline.com |
| S-(+)-Atomoxetine Hydrochloride | S-(+)-Atomoxetine Hydrochloride is an enatiomer of Atomoxetine, which is a selective norepinephrine (NE) reuptake inhibitor for the treatment of attention-deficit hyperactivity disorder (ADHD). Uses: The enatiomer of atomoxetine, a norepinephrine uptake blocker. Alternative Names: (γS)-N-Methyl-γ-(2-methylphenoxy)benzenepropanamine Hydrochloride; (S)-(+)-Tomoxetine Hydrochloride; (S)-Tomoxetine Hydrochloride; LY 139602; Atomoxetine EP Impurity B; Ent S-(+)-atomoxetine hydrochloride. Grades: ≥95%. CAS No. 82857-39-4. Molecular formula: C17H22ClNO. Mole weight: 291.82. | |
| Satoreotide | Satoreotide (JR11) is a SSTR2 antagonist. Satoreotide is usually conjugated with radiolabeled chelators used in neuroendocrine tumor imaing[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: JR11. CAS No. 1801415-23-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P10137. | |
| Satoreotide Tetraxetan | Satoreotide Tetraxetan is a somatostatin receptor 2 (SSTR2) antagonist. Satoreotide Tetraxetan, commonly labeled by 68Ga, is used for paired imaging in neuroendocrine tumors (NETs) research. Alternative Names: DOTA satoreotide; Satoreotide DOTA; DOTA-JR-11; DOTA-JR11. CAS No. 1039726-31-2. Molecular formula: C74H98ClN19O21S2. Mole weight: 1689.27. | |
| Satralizumab | Satralizumab is a humanized monoclonal antibody that targets IL-6R. Satralizumab prevents dTAA formation and progression in rattus norvegicus. Satralizumab can be used for neuromyelitis optica spectrum disorder (NMOSD) and descending thoracic aorta aneurysm (dTAA) research[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: RG-6168; SA-237. CAS No. 1535963-91-7. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-P99112. | |
| Satraplatin | Satraplatin is an alkylating agent, with potent antitumor effect. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BMS182751; BMY45594; JM216. CAS No. 129580-63-8. Pack Sizes: 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-17576. | |
| Satraplatin | Satraplatin, also known as JM216, is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. It has not yet received approval from the U.S. Food and Drug Administration. First mentioned in the medical literature in 1993, satraplatin is the first orally active platinum-based chemotherapeutic drug; other available platinum analogues-cisplatin, carboplatin, and oxaliplatin-must be given intravenously. It is made available in the United States jointly by Spectrum Pharmaceuticals and GPC Biotech under the name SPERA (Satraplatin Expanded Rapid Access). The drug has also been used in the treatment of lung and ovarian cancers. The proposed mode of action is that the compound binds to the DNA of cancer cells rendering them incapable of dividing. Alternative Names: BMS-182751; BMS 182751; BMS182751; JM 216; JM216; JM-216. CAS No. 129580-63-8. Molecular formula: C10H24Cl2N2O4Pt. Mole weight: 500.28. | |
| Satratoxin G | Satratoxin G is a large cyclic mucor toxin. Satratoxin G induces apoptosis by activation of caspase[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 53126-63-9. Pack Sizes: 500 μg; 1 mg; 5 mg. Product ID: HY-130476. | |
| Satratoxin H | Satratoxin H is a toxic metabolite of Stachybotrys atra. Satratoxin H induces caspase-3 and PARP cleavage via p38 MAPK and JNK pathways, stimulates JNK, ERK, and p38 MAPK phosphorylation, and activates JNK and p38 MAPK in a glutathione-sensitive manner. Satratoxin H induces DNA double-stranded breaks, apoptotic body formation, intracellular reactive oxygen species generation, and endoplasmic reticulum stress via ATF6, PERK, and RE1 pathways. Satratoxin H can be used for the research of central nervous system disorders and melanoma[1][2][3][4]. Uses: Scientific research. Category: Signaling pathways. CAS No. 53126-64-0. Pack Sizes: 500 μg. Product ID: HY-123647. | |
| SATURATED POLYESTERS | SATURATED POLYESTERS. |  |
| Sauchinone | Sauchinone is a diastereomeric lignan isolated from Saururus chinensis (Saururaceae). Sauchinone inhibits LPS-inducible iNOS, TNF-α and COX-2 expression through suppression of I-κBα phosphorylation and p65 nuclear translocation. Sauchinone has anti-inflammatory and antioxidant activity[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 177931-17-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-N0613. | |
| Sauchinone | Sauchinone. Group: Biochemicals. Grades: Plant Grade. CAS No. 177931-17-8. Pack Sizes: 20mg. Molecular Formula: C20H20O6, Molecular Weight: 356.37. US Biological Life Sciences. | Worldwide |
| Sauchinone | Sauchinone, coming from the herbs of Saururus chinensis(Lour.) Baill, is a useful adjunctive treatment for bacterial infection. Sauchinone inhibited oxidative stress, as assessed by stainings of 4-hydroxynonenal and nitrotyrosine: these events may have a role in its inhibitory effects on HSCs activation. Sauchinone attenuated CCl4-induced liver fibrosis and TGF-β1-induced HSCs activation, which might be, at least in part, mediated by suppressing autophagy and oxidative stress in HSCs. Sauchinone protects skin keratinocytes through inhibition of extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38 MAPK signaling via upregulation of oxidative defense enzymes. Uses: Anti-inflammatory / antibacterial. Alternative Names: (5aR,7R,8S,8aR,14aS,14bR)-5a,6,7,8,8a,14b-Hexahydro-7,8-dimethyl-5H-Benzo[kl]bis[1,3]dioxolo[4,5-b:4',5'-g]xanthen-5-one; (5aα,7α,8β,8aβ,14aS*,14bβ)-5a,6,7,8,8a,14b-Hexahydro-7,8-dimethyl-5H-benzo[kl]bis[1,3]dioxolo[4,5-b:4',5'-g]xanthen-5-one. Grades: >98%. CAS No. 177931-17-8. Molecular formula: C20H20O6. Mole weight: 356.36. | |
| Sauvagine | Sauvagine. Group: Biochemicals. Grades: Purified. CAS No. 74434-59-6. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Sauvagine | Sauvagine is a corticotropin-releasing factor (CRF) receptor agonist (Ki = 9.4, 9.9, and 3.8 nM for inhibition of 125I-[D-Tyr1]astressin binding to hCRF-R1, rCRF-R2a and mCRF-R2b, respectively). Alternative Names: H-Pyr-Gly-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Ser-Leu-Glu-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2. Grades: >96%. CAS No. 74434-59-6. Molecular formula: C202H346N56O63S. Mole weight: 4599.35. | |
| Savinin | Savinin isolated from the heartwood of Pterocarpus santalinus. It exhibits potent spermicidal activity and significant insecticidal activity. Uses: Antifungal. Alternative Names: (4R)-4,5-Dihydro-4-(1,3-benzodioxole-5-ylmethyl)-3-[(E)-1,3-benzodioxol-5-ylmethylene]furan-2(3H)-one; (3E,4R)-4-(1,3-benzodioxol-5-ylmethyl)-3-(1,3-benzodioxol-5-ylmethylidene)oxolan-2-one. Grades: 97.5%. CAS No. 493-95-8. Molecular formula: C20H16O6. Mole weight: 352.3. | |
| Savolitinib | Savolitinib is a tyrosine kinase inhibitor with potential anticancer activity. Alternative Names: Volitinib; HMPL 504; HMPL0-504; HMPL504; AZD 6094; AZD 6094; AZD-6094; Savolitinib. Grades: >98%. CAS No. 1313725-88-0. Molecular formula: C17H15N9. Mole weight: 345.37. | |
| Savolitinib | Savolitinib (AZD-6094) is a potent, highly selective, and orally bioavailable c-Met inhibitor with IC50 s of 5 nM and 3 nM for c-Met and p-Met, respectively. Savolitinib (AZD-6094) selectively binds to and inhibits the activation of c-Met in an ATP-competitive manner, and disrupts c-Met signal transduction pathways. Antineoplastic activity[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Volitinib; HMPL-504; AZD-6094. CAS No. 1313725-88-0. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-15959. | |
| Saw Palmeto Berry Extract (Standard) | Saw Palmetto (Serenoa Repens): The medicinal parts are the partially dried ripe fruit, the ripe fresh fruit and the ripe dried fruit, The plant is indigenous to the coastal regions of the southern states of the U.S., from South Carolina to Florida and southern California. Applications: Anti-androgenic effects: the lipophilic extract of the herb inhibits binding of dihydrotestosterone (dht) to the cytosolic androgenic receptor and alpha-1 adrenergic receptor in the prostate, thus preventing accumulation of the steroid, which may lead to prostate hyperplasia.anti-inflammatory effects: the extracts of the herb have demonstrated anti-inflammatory activity. inhibition of the synthesis of arachidonic acid inflammatory metobolits, through a double blocking of cyclooxygenas and 5-lipoxy-genase pathways results in anti-inflammatory properties. Group: Others. Purity: 25.0%,45.0% Fatty Acids GC. Saw Palmeto Berry Extract (Standard). Cat No: EXTW-014. |  |
| Saw Palmetto Berry P.E. 45% Fatty Acids GC | Saw Palmetto Berry P.E. 45% Fatty Acids GC. |  CA, FL & NJ |
| Saw Palmetto Extract | Saw Palmetto Extract is produced from the fruits of Serenoa serrulata. These fruit extracts are claimed to be effective treatments for seborrhoea, moisturizing, acne and hair loss. Alternative Names: sabal serrulata extract;SAW PALMETTO EXTRACT;SERENOA EXTRACT;Sabal serrulatum, ext.;SERENOA SERRULATA FRUIT EXTRACT;Einecs 283-292-4;Extract of saw palmetto;Prosta urgenin. CAS No. 84604-15-9. Product ID: CI-HC-0197. Molecular formula: Unspecified. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| Saw Palmetto Extract | Saw palmetto extract is prepared from the the fruit of serenoa repens, which is the sole species currently classified in the genus Serenoa. Saw palmetto extract is rich in fatty acid and phytosterols. Saw palmetto extract has been used in traditional medicine for a variety of indications, most notably benign prostatic hyperplasia. Group: Others. Saw Palmetto Extract; Serenoa Repens (Bartram) Small. Cat No: EXTC-021. | |
| Saw Palmetto Powder & P.E. 4:1 | Saw Palmetto Powder & P.E. 4:1. | CA, FL & NJ |
| Saxagliptin | Saxagliptin (BMS-477118) is a potent, selective, reversible, competitive and orally active dipeptidyl peptidase-4 (DPP-4) (Ki = 0.6-1.3 nM) inhibitor. Saxagliptin has the peotential for type 2 diabetes mellitus research[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BMS-477118. CAS No. 361442-04-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-10285. | |
Our database is helping our users find suppliers everyday.
